Think Research Corporation (THNK.V)
| Previous Close | 0.1900 |
| Open | 0.1700 |
| Bid | 0.1600 x N/A |
| Ask | 0.1700 x N/A |
| Day's Range | 0.1700 - 0.1700 |
| 52 Week Range | 0.1500 - 0.6900 |
| Volume | |
| Avg. Volume | 23,442 |
| Market Cap | 13.396M |
| Beta (5Y Monthly) | 0.56 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.2100 |
| Earnings Date | Nov 27, 2023 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 0.55 |
ACCESSWIREThink Research's Learning Management System to Support Healthcare Professional Education and Training
3-Year SaaS Agreement entered earlier this year Provides Clinical Trial Site Onboarding and Training to Clinical Research AssociatesRe-occurring contract as a white-labelled, bolt-on education platform for a global pharmaceutical company, supporting ...
- ACCESSWIRE
Think Research Announces Grant of Equity Compensation
TORONTO, ON / ACCESSWIRE / December 6, 2023 / Think Research Corporation (TSXV:THNK) ("Think" or the "Company"), a company focused on transforming healthcare through integrated digital health software solutions, today announced that on November 30, ...
- ACCESSWIRE
Think Research Corporation Announces Third Quarter 2023 Results
Annual Recurring Revenue increased by 71% to $24.6 millionHigher Margin Software & Data Revenue represents 56% of total revenue for Q3/23TORONTO, ON / ACCESSWIRE / November 27, 2023 / Think Research Corporation (TSX.V:THNK) ("Think" or the "Company"), ...
